| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |